Cambridge, UK, 14th October 2019: Mogrify Ltd (Mogrify), a UK company aiming to transform the development of life-saving cell therapies, today announced the initial close of its Series A funding. The Company raised $16 million USD in this round, bringing the total investment to over $20 million USD to date. The funding will support internal cell therapy programs, and the development and out-license of novel IP relating to cell conversions of broad therapeutic interest. Mogrify is also actively recruiting, and will increase headcount to 60 scientific, operational and commercial staff located…
Cambridge UK: 11 October 2019
GlobalData has become the latest Partner to join forces with One Nucleus. The One Nucleus Partner Programme is tailor-made to meet the needs both of the Partner and the interests of One Nucleus members.Saief Kazmi, Account Director commented ‘GlobalData are committed to supporting innovation and advances in healthcare and we are delighted to partner with One Nucleus and the magnificent cluster of talent and scientific acumen. Should members be seeking partners, new clients, funding or looking to better understand existing or new therapy areas our…
Clinical Professionals fully fund and train some of the UK’s brightest life science graduates with the aim of giving back and assisting in the future of the industry talent pool and future skilled professionals.The Parliamentary Review, co-chaired by former ministers Lord Pickles and Lord Blunkett, publishes its latest, highly anticipated edition this September. Featuring commentary from the prime minister and senior politicians alongside business and thought leaders across both the private and public sectors, The Review aims to share and promote best practice among executives and…
Reading Scientific Services Ltd (RSSL) secures Enlighted Employer Award in recognition of its exceptional commitment to gender equality in the workplace.
RSSL was named most Enlightened Employer at this year’s Women in Business Awards; a Thames Valley initiative set up to empower businesswomen and showcase organisations that “create a better balance for better business.” With female employees making up 65% of its 300 staff, a female majority in its leadership team and inspirational female role models at every level, RSSL successfully demonstrated itself to be “a truly worthy winner”…
Nadhim Zahawi MP has announced that Stevenage Bioscience Catalyst (SBC) has been successful in its application to become a Life Science Opportunity Zone.
The assessment panel consisted of senior industry life science experts and senior government officials. In a letter to Stevenage Bioscience Catalyst Chief Executive Officer Dr Sally Ann Forsyth, the Minister stated: “l am delighted to tell you that your application has been successful. The panel were impressed by your plans to grow what is already a successful biomedical campus.”
The Minister made the formal announcement at Hertfordshire…
Harlow Council and One Nucleus would like to announce that after eight successful years the M11 Health Enterprise Forum will join the London Stansted Cambridge Consortium (LSCC) in its efforts to promote the Innovation Corridor https://innovationcorridor.uk/ that exists from King's Cross to Peterborough.
In addition, Professor Gino Martini Chief Scientist of the Royal Pharmaceutical Society and resident of Harlow and co-founder of the M11 Health Enterprise Forum will join the LSCC as Deputy Chair.
Professor Martini commenting on the changes 'The addition of the M11…
Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces completion of dosing and all patient visits in its Phase I clinical trial for its ultra-rapid acting insulin product candidate, AT247.
Arecor’s AT247 is an ultra-rapid acting prandial insulin product candidate targeting improved treatment for people living with Type I diabetes. The novel formulation of AT247 is designed to deliver an acceleration of insulin absorption, post injection, to enable more effective management of blood glucose levels.…
Leading Cambridge and international intellectual property (IP) firm Marks & Clerk is to host the Cambridge IP Summit, taking place on Thursday 10 October at the Hilton Hotel, Cambridge.
The event aims to build upon the success of last year’s summit, which brought leading businesses from Cambridge and beyond together to discuss how to protect high-tech innovation.
The one day event provides a forum for in-house IP teams, general counsel, investors, CEOs, CTOs and senior decision makers to come together to discuss and analyse the key issues impacting innovative and technology driven…
Westbury, NY – Oct. 2, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has appointed Lori Ball as its chief operating officer (COO). In her new position, Ms. Ball will be responsible for providing leadership and strategic direction on operational and business decisions, including growth planning, business and organizational development, risk management, and quality control.
“Lori has the requisite business expansion, global supply chain and regulatory expertise to help us take BioIVT through the next phase of its…